University of Crete (UOC)
Genetic study of Parkinson's disease on the island of Crete
Abstract
dc:descriptionBackground: Parkinson’s disease (PD) is a complex neurodegenerative disorder with both genetic and environmental underpinnings. While several large – scale international initiatives have characterized genetic risk factors in diverse populations, data from island-based Mediterranean populations remain scarce. This thesis presents the first comprehensive genetic study of PD in Crete, a population with distinct demographic, geographical, and historical features from the Greek mainland that may have influenced genetic architecture. Objectives: We investigated the genetic landscape of PD in the island – based population of Crete by establishing the Cretan PD Cohort (CPDC) and creating a biobank to study the genetic particularities of the Cretan population, to make genotype-phenotype associations, and to enable current and future research initiatives and collaborations. Methods: Clinical information and DNA samples from PD patients and age - and sex - matched controls were collected during a four-year period (2020 – 2024) from the Cretan population. Samples were analyzed using a combination of methods, including a genotyping array (NeuroBooster Array version 1.0) for both patients and controls, targeted screening for the GBA1 variants p.N409S and p.L483P for the patient cohort via PCR (polymerase chain reaction) – based methods, and whole exome sequencing (WES) in selected patients who were suspected for genetic PD (early - onset or/ and familial PD cases). Detected variants were classified according to well-established criteria (American College of Medical Genetics and Genomics, ACMG). Results: DNA samples from 360 index patients and 251 controls were included. A molecular diagnosis (heterozygous dominant/ homozygous recessive pathogenic/likely pathogenic non-GBA1 variant) was identified in 3.1% of patients, including LRRK2 - PD (n = 4) and SNCA - PD (n = 1). A novel homozygous PINK1 variant (p.Y295Ter) and a rare homozygous FIG4 variant (p.I41T) were detected in two early-onset cases and other characteristics of recessive PD (e.g., dystonia). About 10.3% of patients carried a GBA1 variant, including four rare variants (p.C55S, p.H294Q, p.K237T, p.R502H), and had an adjusted earlier disease onset of 7.3 years (95% Confidence Intervals: -10.8 to -3.8, p < 0.0001). Additionally, GBA1 carriers had a 4.3-fold higher risk for PD compared to non-carriers (Odds Ratio, OR = 4.29, 95% CI: 1.61 – 14.8, p = 0.008). Discussion: These findings highlight the distinct genetic profile of PD in the Cretan population and support the use of targeted genetic testing and counseling. Given the growing relevance of GBA1 - and LRRK2 - specific findings in clinical trials and emerging therapies, these insights are of paramount clinical importance.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Boura, Iro
- Μπούρα, Ηρώ
Subjects
dc:subject × 14Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60810